TY - JOUR
T1 - Burden of non-communicable disease studies in Europe
T2 - a systematic review of data sources and methodological choices
AU - Charalampous, Periklis
AU - Gorasso, Vanessa
AU - Plass, Dietrich
AU - Pires, Sara M
AU - von der Lippe, Elena
AU - Mereke, Alibek
AU - Idavain, Jane
AU - Kissimova-Skarbek, Katarzyna
AU - Morgado, Joana Nazaré
AU - Ngwa, Che Henry
AU - Noguer, Isabel
AU - Padron-Monedero, Alicia
AU - Santi-Cano, María José
AU - Sarmiento, Rodrigo
AU - Devleesschauwer, Brecht
AU - Haagsma, Juanita A
AU - COST Action CA18218 participants
AU - Samouda, Hanène
N1 - Funding:The authors received no specific funding for this work.
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association.
PY - 2022/4/1
Y1 - 2022/4/1
N2 - BACKGROUND: Assessment of disability-adjusted life years (DALYs) resulting from non-communicable diseases (NCDs) requires specific calculation methods and input data. The aims of this study were to: (i) identify existing NCD burden of disease (BoD) activities in Europe; (ii) collate information on data sources for mortality and morbidity; and (iii) provide an overview of NCD-specific methods for calculating NCD DALYs.METHODS: NCD BoD studies were systematically searched in international electronic literature databases and in grey literature. We included all BoD studies that used the DALY metric to quantify the health impact of one or more NCDs in countries belonging to the European Region.RESULTS: A total of 163 BoD studies were retained: 96 (59%) were single-country or sub-national studies and 67 (41%) considered more than one country. Of the single-country studies, 29 (30%) consisted of secondary analyses using existing Global Burden of Disease (GBD) results. Mortality data were mainly derived (49%) from vital statistics. Morbidity data were frequently (40%) drawn from routine administrative and survey datasets, including disease registries and hospital discharge databases. The majority (60%) of national BoD studies reported mortality corrections. Multimorbidity adjustments were performed in 18% of national BoD studies.CONCLUSION: The number of national NCD BoD assessments across Europe increased over time, driven by an increase in BoD studies that consisted of secondary data analysis of GBD study findings. Ambiguity in reporting of the use of NCD-specific BoD methods underline the need for reporting guidelines of BoD studies to enhance transparency of NCD BoD estimates across Europe.
AB - BACKGROUND: Assessment of disability-adjusted life years (DALYs) resulting from non-communicable diseases (NCDs) requires specific calculation methods and input data. The aims of this study were to: (i) identify existing NCD burden of disease (BoD) activities in Europe; (ii) collate information on data sources for mortality and morbidity; and (iii) provide an overview of NCD-specific methods for calculating NCD DALYs.METHODS: NCD BoD studies were systematically searched in international electronic literature databases and in grey literature. We included all BoD studies that used the DALY metric to quantify the health impact of one or more NCDs in countries belonging to the European Region.RESULTS: A total of 163 BoD studies were retained: 96 (59%) were single-country or sub-national studies and 67 (41%) considered more than one country. Of the single-country studies, 29 (30%) consisted of secondary analyses using existing Global Burden of Disease (GBD) results. Mortality data were mainly derived (49%) from vital statistics. Morbidity data were frequently (40%) drawn from routine administrative and survey datasets, including disease registries and hospital discharge databases. The majority (60%) of national BoD studies reported mortality corrections. Multimorbidity adjustments were performed in 18% of national BoD studies.CONCLUSION: The number of national NCD BoD assessments across Europe increased over time, driven by an increase in BoD studies that consisted of secondary data analysis of GBD study findings. Ambiguity in reporting of the use of NCD-specific BoD methods underline the need for reporting guidelines of BoD studies to enhance transparency of NCD BoD estimates across Europe.
UR - https://pubmed.ncbi.nlm.nih.gov/35015851/
U2 - 10.1093/eurpub/ckab218
DO - 10.1093/eurpub/ckab218
M3 - Article
C2 - 35015851
VL - 32
SP - 289
EP - 296
JO - European Journal of Public Health
JF - European Journal of Public Health
SN - 1101-1262
IS - 2
ER -